Not applicableStudy completedNCT00705809What this trial is testingT-Cell Project: Epidemiologic ComponentWho this might be right forPeripheral T-Cell Lymphoma National Cancer Institute (NCI) 800
Testing effectiveness (Phase 2)Study completedNCT00066599What this trial is testingVoriconazole in Preventing Fungal Infections in Children With Neutropenia After ChemotherapyWho this might be right forKidney CancerLeukemiaLymphoma+6 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)WithdrawnNCT00310128What this trial is testingCombination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's LymphomaWho this might be right forAIDS-related LymphomaAdult Non-Hodgkin's LymphomaAnaplastic Large Cell Lymphoma AIDS Malignancy Consortium
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07180771What this trial is testingBosmolisib (BR101801) in Participants With R/R PTCL.Who this might be right forPeripheral T Cell Lymphoma Boryung Pharmaceutical Co., Ltd 44
Testing effectiveness (Phase 2)Study completedNCT00105001What this trial is testingTacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic CancerWho this might be right forMyelodysplastic/Myeloproliferative Neoplasm, UnclassifiablePreviously Treated Myelodysplastic SyndromeRefractory Chronic Lymphocytic Leukemia+113 more Fred Hutchinson Cancer Center 210
Early research (Phase 1)Temporarily pausedNCT04828174What this trial is testingAnti-TRBC1 CAR-T Cell Therapy in Patients With TRBC1 Positive T Cell MalignanciesWho this might be right forPeripheral T Cell LymphomaAngioimmunoblastic T-cell LymphomaAnaplastic Lymphoma+2 more Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 9
Not applicableUnknownNCT03000738What this trial is testingThe Value and Mechanisms for Monocytes Subpopulations in Predicting the Prognosis of LymphomasWho this might be right forLymphoma,Non-HodgkinDiffuse Large B Cell LymphomaPeripheral T-Cell Lymphoma Peking Union Medical College Hospital 100
Testing effectiveness (Phase 2)UnknownNCT00363090What this trial is testingAlemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's LymphomaWho this might be right forLymphoma Toronto Sunnybrook Regional Cancer Centre 84
Testing effectiveness (Phase 2)Study completedNCT00644189What this trial is testingOral Clofarabine for Relapsed/Refractory Non-Hodgkin LymphomaWho this might be right forFollicular LymphomaMarginal Zone LymphomaMantle Cell Lymphoma+7 more Massachusetts General Hospital 50
Large-scale testing (Phase 3)UnknownNCT01316744What this trial is testingKetamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic PainWho this might be right forCancer University of Glasgow 214
Testing effectiveness (Phase 2)Ended earlyNCT05883449What this trial is testingPhase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCLWho this might be right forRelapsed or Refractory Hodgkin LymphomaPeripheral T Cell Lymphoma Affimed GmbH 25
Testing effectiveness (Phase 2)Study completedNCT00109928What this trial is testingS0350 Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Peripheral T-Cell Non-Hodgkin's LymphomaWho this might be right forLymphoma SWOG Cancer Research Network 34
Testing effectiveness (Phase 2)UnknownNCT01307592What this trial is testingGemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin LymphomaWho this might be right forLymphoma Auxilio Mutuo Cancer Center 70
Testing effectiveness (Phase 2)Study completedNCT03052933What this trial is testingCopanlisib and Gemcitabine in Relapsed/Refractory PTCLWho this might be right forMature T-Cell and NK-Cell Neoplasm Chonnam National University Hospital 28
Early research (Phase 1)Study completedNCT01607892What this trial is testingSafety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological CancerWho this might be right forHematological Malignancies Karyopharm Therapeutics Inc 286
Testing effectiveness (Phase 2)UnknownNCT02404571What this trial is testingGDP in Frontline Chemotherapy for Patients With PTCL-NOSWho this might be right forLymphoma, T-Cell, Peripheral Chinese Academy of Medical Sciences 28
Testing effectiveness (Phase 2)Looking for participantsNCT06151106What this trial is testingChidamide and Duvalisibon for the Treatment of Refractory/Relapsed Peripheral T-cell LymphomaWho this might be right forPeripheral T Cell LymphomaRelapsed Peripheral T-Cell LymphomaRefractory T-Cell Lymphoma The First Affiliated Hospital of Xiamen University 33
Testing effectiveness (Phase 2)Study completedNCT01611142What this trial is testingStudy of KW-0761 (Mogamulizumab) in Subjects With Previously Treated Peripheral T-cell Lymphoma (PTCL)Who this might be right forPeripheral T-Cell Lymphoma Kyowa Kirin Co., Ltd. 38
Early research (Phase 1)UnknownNCT03921879What this trial is testingSafety and Efficacy of OT-82 in Participants With Relapsed or Refractory LymphomaWho this might be right forLymphomaLymphoma, Non-HodgkinLymphoma, B-Cell+4 more Oncotartis, Inc. 50
Not applicableLooking for participantsNCT04045470What this trial is testingA Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell LymphomaWho this might be right forCutaneous T Cell LymphomaPeripheral T Cell Lymphoma Dana-Farber Cancer Institute 20